Position statement

Nonanesthesiologist administration of propofol for GI endoscopy

John J. Vargo, Lawrence B. Cohen, Douglas Rex, Paul Y. Kwo

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

This statement on the use of nonanesthesiologist-administered propofol (NAAP) for GI endoscopy is issued jointly by The American Association for the Study of Liver Diseases, American College of Gastroenterology, American Gastroenterological Association, and American Society for Gastrointestinal Endoscopy. A 4-member committee, composed of a representative from each society, prepared the first draft of this document, which was then reviewed and approved by the governing board of each organization. This document is designed to provide an evidence-based assessment of propofol-mediated sedation by properly trained gastroenterologists and other nonanesthesiologists. The safety, efficacy, cost-effectiveness, and training issues involved with nonanesthesiologist administration of propofol for GI endoscopy are reviewed, and a series of concluding statements and recommendations are provided. Whenever possible, these summary conclusions are graded based upon the strength of the supporting evidence (Table 1).

Original languageEnglish
Pages (from-to)1683-1689
Number of pages7
JournalHepatology
Volume50
Issue number6
DOIs
StatePublished - 2009

Fingerprint

Propofol
Endoscopy
Governing Board
Committee Membership
Gastrointestinal Endoscopy
Cost-Benefit Analysis
Organizations
Safety

ASJC Scopus subject areas

  • Hepatology

Cite this

Position statement : Nonanesthesiologist administration of propofol for GI endoscopy. / Vargo, John J.; Cohen, Lawrence B.; Rex, Douglas; Kwo, Paul Y.

In: Hepatology, Vol. 50, No. 6, 2009, p. 1683-1689.

Research output: Contribution to journalArticle

Vargo, John J. ; Cohen, Lawrence B. ; Rex, Douglas ; Kwo, Paul Y. / Position statement : Nonanesthesiologist administration of propofol for GI endoscopy. In: Hepatology. 2009 ; Vol. 50, No. 6. pp. 1683-1689.
@article{cdc2b3eb90bd4c07b777aeabcb910cce,
title = "Position statement: Nonanesthesiologist administration of propofol for GI endoscopy",
abstract = "This statement on the use of nonanesthesiologist-administered propofol (NAAP) for GI endoscopy is issued jointly by The American Association for the Study of Liver Diseases, American College of Gastroenterology, American Gastroenterological Association, and American Society for Gastrointestinal Endoscopy. A 4-member committee, composed of a representative from each society, prepared the first draft of this document, which was then reviewed and approved by the governing board of each organization. This document is designed to provide an evidence-based assessment of propofol-mediated sedation by properly trained gastroenterologists and other nonanesthesiologists. The safety, efficacy, cost-effectiveness, and training issues involved with nonanesthesiologist administration of propofol for GI endoscopy are reviewed, and a series of concluding statements and recommendations are provided. Whenever possible, these summary conclusions are graded based upon the strength of the supporting evidence (Table 1).",
author = "Vargo, {John J.} and Cohen, {Lawrence B.} and Douglas Rex and Kwo, {Paul Y.}",
year = "2009",
doi = "10.1002/hep.23326",
language = "English",
volume = "50",
pages = "1683--1689",
journal = "Hepatology",
issn = "0270-9139",
publisher = "John Wiley and Sons Ltd",
number = "6",

}

TY - JOUR

T1 - Position statement

T2 - Nonanesthesiologist administration of propofol for GI endoscopy

AU - Vargo, John J.

AU - Cohen, Lawrence B.

AU - Rex, Douglas

AU - Kwo, Paul Y.

PY - 2009

Y1 - 2009

N2 - This statement on the use of nonanesthesiologist-administered propofol (NAAP) for GI endoscopy is issued jointly by The American Association for the Study of Liver Diseases, American College of Gastroenterology, American Gastroenterological Association, and American Society for Gastrointestinal Endoscopy. A 4-member committee, composed of a representative from each society, prepared the first draft of this document, which was then reviewed and approved by the governing board of each organization. This document is designed to provide an evidence-based assessment of propofol-mediated sedation by properly trained gastroenterologists and other nonanesthesiologists. The safety, efficacy, cost-effectiveness, and training issues involved with nonanesthesiologist administration of propofol for GI endoscopy are reviewed, and a series of concluding statements and recommendations are provided. Whenever possible, these summary conclusions are graded based upon the strength of the supporting evidence (Table 1).

AB - This statement on the use of nonanesthesiologist-administered propofol (NAAP) for GI endoscopy is issued jointly by The American Association for the Study of Liver Diseases, American College of Gastroenterology, American Gastroenterological Association, and American Society for Gastrointestinal Endoscopy. A 4-member committee, composed of a representative from each society, prepared the first draft of this document, which was then reviewed and approved by the governing board of each organization. This document is designed to provide an evidence-based assessment of propofol-mediated sedation by properly trained gastroenterologists and other nonanesthesiologists. The safety, efficacy, cost-effectiveness, and training issues involved with nonanesthesiologist administration of propofol for GI endoscopy are reviewed, and a series of concluding statements and recommendations are provided. Whenever possible, these summary conclusions are graded based upon the strength of the supporting evidence (Table 1).

UR - http://www.scopus.com/inward/record.url?scp=73149094978&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=73149094978&partnerID=8YFLogxK

U2 - 10.1002/hep.23326

DO - 10.1002/hep.23326

M3 - Article

VL - 50

SP - 1683

EP - 1689

JO - Hepatology

JF - Hepatology

SN - 0270-9139

IS - 6

ER -